
Sanity Group
Unlocking the potential of cannabinoids to develop innovative pharmaceuticals and well-being products.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
investor investor investor investor investor investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
investor | €0.0 | round | |
* | $12.3m | Convertible | |
Total Funding | 000k |
EUR | 2019 | 2020 | 2021 | 2025 |
---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 |
EBITDA | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
A holding company specializing in cannabinoid-based products, with a focus on pharmaceuticals, wellbeing, and cosmetics. The company's business model includes the import, distribution, and development of CBD and THC products across Europe.
Sanity Group operates in the European cannabis market, targeting both the medical and wellness sectors. The company's revenue is generated through the sale of its diverse product portfolio, which includes medical cannabis brands like ZOIKS, as well as other wellbeing and cosmetic items. The company is also actively involved in shaping the legal cannabis market in Germany through participation in scientific pilot projects for the establishment of specialized cannabis stores.
Keywords: cannabinoids, medical cannabis, pharmaceuticals, wellbeing products, CBD, THC, European cannabis market, cannabis distribution, cannabis research, cosmetic products